PDL BioPharma Announces Record Date for October 1 Dividend Payment

INCLINE VILLAGE, Nev., June 10 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc.
(PDL) (Nasdaq: PDLI) today announced that all shareholders owning shares of
PDL on September 17, 2009, will be paid a dividend of $0.50 per share on
October 1, 2009. The Company previously announced that it would pay two
dividends, each in the amount of $0.50 per share, to its stockholders in 2009.
The first dividend was paid on April 1, 2009 to all stockholders who owned
shares of PDL on March 16, 2009.

About PDL BioPharma, Inc.
PDL BioPharma pioneered the humanization of monoclonal antibodies and, by
doing so, enabled the discovery of a new generation of targeted treatments for
cancer and immunologic diseases. PDL is focused on maximizing the value of its
antibody humanization patents and related assets. The company receives
royalties on sales of a number of humanized antibody products marketed today
and also may receive royalty payments on additional humanized antibody
products launched before patent expiry in late 2014. For more information,
please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of
PDL BioPharma, Inc.

SOURCE PDL BioPharma, Inc.

Danielle Bertrand of WeissComm Partners, +1-415-946-1056,
dbertrand@wcpglobal.com, for PDL BioPharma, Inc.